Guide to Drug Financing Mechanisms
(1998; 64 pages) [French] [Spanish]
Table des matières
Afficher le documentForeword
Afficher le documentAcknowledgements
Ouvrir ce répertoire et afficher son contenuIntroduction
Ouvrir ce répertoire et afficher son contenuChapter 1. Selection
Ouvrir ce répertoire et afficher son contenuChapter 2. Procurement
Fermer ce répertoireChapter 3. Distribution
Fermer ce répertoireObjective of distribution
Afficher le documentGeographical access
Afficher le documentPhysical access
Afficher le documentEconomic access
Ouvrir ce répertoire et afficher son contenuImproving distribution
Ouvrir ce répertoire et afficher son contenuFinancing of consumption
Ouvrir ce répertoire et afficher son contenuChapter 4. Prescribing
Ouvrir ce répertoire et afficher son contenuSummary: contributions and limitations of the economic approach
Afficher le documentReferences
Afficher le documentSelected WHO publications of related interest
Afficher le documentBack cover
 

Geographical access

Geographical access refers to the distance patients must travel or the time they need to go to the nearest pharmacy. Geographical access depends on the number and location of pharmacies. In rural areas the proportion of the population that lives within a radius of 5 km of a pharmacy may be taken as indicating geographical access, but this is often complex to measure. A pharmacy in a locality where there is no prescriber is of little use, so the presence or absence of pharmacies associated with health services should then be taken as an indicator (Table 9).

Optimizing geographical access must balance the extra cost of pharmacies serving small populations against the cost to those populations of travel to more distant pharmacies. To finance these extra costs, subsidies need to be established by the government, by local authorities, or by taxes on pharmacies in the large cities.

vers la section précédente vers la section suivante
 

Dernière mise à jour: le 3 mai 2013